Lv31
220 积分 2022-12-12 加入
Lp(a): A Rapidly Evolving Therapeutic Landscape
2小时前
已完结
Lepodisiran — A Long-Duration Small Interfering RNA Targeting Lipoprotein(a)
2小时前
已完结
Lepodisiran, an Extended-Duration Short Interfering RNA Targeting Lipoprotein(a)
2小时前
已完结
Discovery of AZD8421: A Potent CDK2 Inhibitor with Selectivity Against Other CDK Family Members and the Human Kinome
22天前
已完结
Revolutionizing Synthetic Antibody Design: Harnessing Artificial Intelligence and Deep Sequencing Big Data for Unprecedented Advances
2个月前
已完结
Machine learning for functional protein design
2个月前
已完结
A new era of antibody discovery: an in-depth review of AI-driven approaches
2个月前
已完结
AI-driven antibody design with generative diffusion models: current insights and future directions
2个月前
已完结
Preclinical efficacy and pharmacokinetics of an RNA-encoded T cell–engaging bispecific antibody targeting human claudin 6
3个月前
已完结
Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
4个月前
已完结
皖公网安备34019202002308
